Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Tech sector outlook
9th Mar 2026
Real Estate Credit Investments (RECI)
Manager presentation and Q&A
4th Mar 2026
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
130: How deeptech can insulate investors from AI software concerns | Ilian Iliev of EMV Capital
Stay up-to-date with the latest research
Sign up to our newsletter
Ranked at number 4 in FeedSpot Podcasts for '10 Best Venture Capital Podcasts UK Edition 2026' -
Leading podcast in EIS
Life Sciences research
Cizzle Biotechnology
Life Sciences
Strategic collaboration with SGSC
By
Dr Martin Hall
20 Sep 2021
Diurnal Group Plc
Life Sciences
All set for three pivotal trials
By
Dr Martin Hall
16 Sep 2021
Stay up-to-date with the latest research
Sign up to our newsletter
Ulisse BioMed
Life Sciences
Molecular diagnostic game changer
By
Jason Streets
06 Sep 2021
Shield Therapeutics Plc
Life Sciences
Focused on US market penetration
By
Dr Martin Hall
20 Aug 2021
Advanced Oncotherapy
Life Sciences
Funded to completion
By
Dr Martin Hall
12 Aug 2021
International Biotechnology Trust
Life Sciences
Investing in a broad spectrum of the drug industry
By
Dr Martin Hall
06 Jul 2021
Tissue Regenix
Life Sciences
Poised for growth
By
Dr Martin Hall
30 Jun 2021
Shield Therapeutics Plc
Life Sciences
Accrufer® launch on schedule
By
Dr Martin Hall
26 May 2021
Incanthera Ltd
Life Sciences
Significant progress in first anniversary as plc
By
Dr Martin Hall
18 May 2021
Cizzle Biotechnology
Life Sciences
Early detection of lung cancer
By
Dr Martin Hall
14 May 2021
Arix Bioscience
Life Sciences
32% IRR since inception in 2016
By
Dr Martin Hall
15 Mar 2021
Prev
1
...
3
4
5
6
7
...
22
Next
